Majella O'Keeffe

Dr. Majella O'Keeffe

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
Marie-Pierre St-OngeMarie-Pierre St-Onge
Marie-Pierre St-Onge
ARAmy L Roberts
Amy L Roberts
JCJinya Chen
Jinya Chen
MKMichael Kelleman
Michael Kelleman
MOMajella O'Keeffe
Majella O'Keeffe
PJPeter J.H. Jones
Peter J.H. Jones
Background: Evidence suggests a relation between short sleep duration and obesity.Objective: We assessed energy balance during periods of short and h

1 November 2012 in SLEEP
Verified
Journal Article
Open access
PDF file
Marie-Pierre St-OngeMarie-Pierre St-Onge
Marie-Pierre St-Onge
MOMajella O'Keeffe
Majella O'Keeffe
ARAmy L. Roberts
Amy L. Roberts
ARArindam RoyChoudhury
Arindam RoyChoudhury
BLBlandine Laferrère
Blandine Laferrère
Study Objective:. To determine the hormonal effects of reducing sleep duration under controlled feeding conditions.Design:. Randomized, crossover study.

1 October 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
ABAndrew A. Butler
Andrew A. Butler
CTCharmaine S. Tam
Charmaine S. Tam
KSKimber L. Stanhope
Kimber L. Stanhope
BWBruce M. Wolfe
Bruce M. Wolfe
MAMohamed R. Ali
Mohamed R. Ali
PHPeter Havel
Peter Havel
Context: Mouse studies suggest that adropin, a peptide hormone, is required for metabolic homeostasis and prevention of obesity-associated insulin resistance. Whether obesity and insulin resistance are associated with low plasma adropin levels in humans is not known. Objectives: Our objective was to investigate the hypothesis that obesity and indicators of insulin resistance are associated with low adropin levels and determine whether weight loss regulates adropin levels. Design and Participants: Plasma was obtained from 85 female [age 21–67 yr, body mass index (BMI) 19.4–71.5 kg/m2] and 45 male (age 18–70 yr, BMI 19.1–62.6 kg/m2) volunteers for other clinical studies. The impact of Roux-en-Y gastric bypass was investigated in 19 obese females (BMI 37–65 kg/m2) using samples collected at baseline and 1–12 months after surgery. Results: Adropin levels correlate negatively with BMI (r = −0.335, P < 0.001) and age (r = −0.263, P=0.003). Age-adjusted adropin levels are higher in males [4.1 ng/ml; 95% confidence interval (CI) = 3.6–4.6 ng/ml] than females (3.0 ng/ml; 95% CI = 2.6–3.4 ng/ml) (P = 0.001). In all subjects, lower age-adjusted adropin levels were observed in overweight (3.3 ng/ml; 95% CI = 2.8–3.8 ng/ml, P = 0.033) and obese (2.7 ng/ml; 95% CI = 2.1–3.3 ng/ml, P = 0.001) compared with healthy-weight subjects (4.1 ng/ml; 95% CI = 3.6–4.5 ng/ml). This effect was gender specific (weight category × gender, P < 0.001) and was observed in males only. Aging and diagnosis with two or more metabolic syndrome risk factors was associated with low adropin levels, irrespective of sex. Adropin concentrations increased after Roux-en-Y gastric bypass, peaking 3 months after surgery (P < 0.01). Conclusions: Although males exhibit higher adropin levels that are reduced by obesity, aging and markers of insulin resistance are associated with low plasma adropin irrespective of sex.

14 July 2017 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
PDF file
MOMajella O'Keeffe
Majella O'Keeffe
CJC. Jansen
C. Jansen
LML. Martin
L. Martin
MWM. Williams
M. Williams
LSL. Seamark
L. Seamark
MLMiranda C E Lomer
Miranda C E Lomer
Background: The low‐FODMAP diet is a frequently used treatment for irritable bowel syndrome (IBS). Most research has focused on short‐term FODMAP restriction; however, guidelines recommend that high‐FODMAP foods are reintroduced to individual tolerance. This study aimed to assess the long‐term effectiveness of the low‐FODMAP diet following FODMAP reintroduction in IBS patients.Methods: Patients with IBS were prospectively recruited to a questionnaire study following completion of dietitian‐led low‐FODMAP education. At baseline and following FODMAP restriction (short term) only, gastrointestinal symptoms were measured as part of routine clinical care. Following FODMAP reintroduction, (long term), symptoms, dietary intake, acceptability, food‐related quality of life (QOL), and healthcare utilization were assessed. Data were reported for patients who continued long‐term FODMAP restriction (adapted FODMAP) and/or returned to a habitual diet (habitual).Key Results: Of 103 patients, satisfactory relief of symptoms was reported in 12% at baseline, 61% at short‐term follow‐up, and 57% at long‐term follow‐up. At long‐term follow‐up, 84 (82%) patients continued an ‘adapted FODMAP’ diet (total FODMAP intake mean 20.6, SD 14.9 g/d) compared with 19 (18%) of patients following a ‘habitual’ diet (29.4, SD 22.9 g/d, P=.039). Nutritional adequacy was not compromised for either group. The ‘adapted FODMAP’ group reported the diet cost significantly more than the ‘habitual’ group (P<.001) and affected social eating (P<.01) but there was no effect on food‐related QOL. Healthcare utilization was similar between both groups.Conclusion and Inferences: Low‐FODMAP education is effective for long‐term IBS management, enables a nutritionally adequate diet, and is broadly acceptable to patients.

12 March 2014 in Epigenetics
Verified
Journal Article
Closed access
KTKatie L Togher
Katie L Togher
MOMajella O'Keeffe
Majella O'Keeffe
AKAli S Khashan
Ali S Khashan
HGHumberto Gutiérrez
Humberto Gutiérrez
LKLouise C Kenny
Louise C Kenny
GOGerard W. O'Keeffe
Gerard W. O'Keeffe
“Fetal programming” is a term used to describe how early-life experience influences fetal development and later disease risk. In humans, prenatal stress-induced fetal programming is associated with increased risk of preterm birth, and a heightened risk of metabolic and neurological diseases later in life. A critical determinant of this is the regulation of fetal exposure to glucocorticoids by the placenta. Glucocorticoids are the mediators through which maternal stress influences fetal development. Excessive fetal glucocorticoid exposure during pregnancy results in low birth weight and abnormalities in a number of tissues. The amount of fetal exposure to maternal glucocorticoids depends on the expression of HSD11B2, an enzyme predominantly produced by the syncytiotrophoblast in the placenta. This protects the fetus by converting active glucocorticoids into inactive forms. In this review we examine recent findings regarding placental HSD11B2 that suggest that its epigenetic regulation may mechanistically l...

1 November 2012 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
PDF file
Ari ShechterAri Shechter
Ari Shechter
MOMajella O'Keeffe
Majella O'Keeffe
ARAmy L. Roberts
Amy L. Roberts
GZGary K. Zammit
Gary K. Zammit
ARArindam RoyChoudhury
Arindam RoyChoudhury
Marie-Pierre St-OngeMarie-Pierre St-Onge
Marie-Pierre St-Onge
Sleep reduction is associated with increased energy intake and weight gain, though few studies have explored the relationship between sleep architecture and energy balance measures in the context of experimental sleep restriction. Fourteen males and 13 females (body mass index: 22–26 kg/m2) participated in a crossover sleep curtailment study. Participants were studied under two sleep conditions: short (4 h/night; 0100–0500 h) and habitual (9 h/night; 2200–0700 h), for 5 nights each. Sleep was polysomnographically recorded nightly. Outcome measures included resting metabolic rate (RMR), feelings of appetite-satiety, and ad libitum food intake. Short sleep resulted in reductions in stage 2 sleep and rapid eye movement (REM) sleep duration ( P < 0.001), as well as decreased percentage of stage 2 sleep and REM sleep and increased slow wave sleep (SWS) percentage ( P < 0.05). Linear mixed model analysis demonstrated a positive association between stage 2 sleep duration and RMR ( P = 0.051). Inverse associations were observed between REM sleep duration and hunger ( P = 0.031) and between stage 2 sleep duration and appetite for sweet ( P = 0.015) and salty ( P = 0.046) foods. Stage 2 sleep percentage was inversely related to energy consumed ( P = 0.024). Stage 2 sleep ( P = 0.005), SWS ( P = 0.008), and REM sleep ( P = 0.048) percentages were inversely related to fat intake, and SWS ( P = 0.040) and REM sleep ( P = 0.050) were inversely related to carbohydrate intake. This study demonstrates that changes in sleep architecture are associated with markers of positive energy balance and indicate a means by which exposure to short sleep duration and/or an altered sleep architecture profile may lead to excess weight gain over time.